Table 1 Patient clinical characteristics and echocardiographic parameters
From: Higher plasma prorenin concentration plays a role in the development of coronary artery disease
Non-CAD group | CAD group | p-value | |
|---|---|---|---|
(n = 26) | (n = 59) | ||
Clinical characteristics | |||
Men (%) | 20 (76.9) | 39 (66.1) | 0.27 |
Age, years | 62 ± 15 | 69 ± 9 | 0.007 |
Body mass index | 22.7 ± 3.1 | 23.8 ± 3.0 | 0.12 |
Hypertension, n (%) | 12 (46.1) | 36 (61.0) | 0.15 |
Diabetes mellitus, n (%) | 5 (19.2) | 28 (47.5) | 0.010 |
Dyslipidemia, n (%) | 5 (19.2) | 32 (56.1) | 0.002 |
Systolic blood pressure (mmHg) | 125 ± 18 | 130 ± 18 | 0.21 |
Diastolic blood pressure (mmHg) | 75 ± 11 | 75 ± 12 | 0.85 |
Echocardiographic parameters | |||
Left ventricular ejection fraction (%) | 70 ± 6 | 62 ± 11 | 0.001 |
LVEDd (mm) | 45 ± 7 | 47 ± 5 | 0.15 |
LVSWth (mm) | 9.2 ± 1.7 | 9.5 ± 1.3 | 0.41 |
LVPWth (mm) | 9.6 ± 1.5 | 9.7 ± 1.5 | 0.72 |
Medications | |||
ARBs or ACEIs, n (%) | 8 (30.8) | 16 (27.1) | 0.81 |
Beta-blockers, n (%) | 3 (11.5) | 9 (15.2) | 0.61 |
Calcium channel blockers, n (%) | 7 (26.9) | 23 (39.0) | 0.23 |
Diuretics, n (%) | 2 (7.7) | 7 (11.9) | 0.71 |